Moderately bullish activity in Moderna (MRNA), with shares up $2.95, or 5.92%, near $52.82. Options volume roughly in line with average with 21k contracts traded and calls leading puts for a put/call ratio of 0.29, compared to a typical level near 0.69. Implied volatility (IV30) is up nearly 13.0 points near 88.28, in the highest 10% of observations over the past year, suggesting an expected daily move of $2.94. Put-call skew steepened, indicating increased demand for downside protection.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Early notable gainers among liquid option names on February 23rd
- Why Is Vanguard S&P 500 ETF (VOO) Down Today, 2/23/2026?
- Moderna price target raised to $69 from $63 at Piper Sandler
- Moderna Faces Default Risk as Ares Capital–Led Lenders Gain Power to Accelerate Debt and Seize Collateral
- Moderna Stock Soars as Flu Reversal Ignites Hopes
